122 related articles for article (PubMed ID: 30429034)
1. Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH score.
Balata H; Foden P; Edwards T; Chaturvedi A; Elshafi M; Tempowski A; Teng B; Whittemore P; Blyth KG; Kidd A; Ellames D; Flint LA; Robson J; Teh E; Jones R; Batchelor T; Crosbie P; Booton R; Evison M
Lung Cancer; 2018 Nov; 125():29-34. PubMed ID: 30429034
[TBL] [Abstract][Full Text] [Related]
2. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
[TBL] [Abstract][Full Text] [Related]
3. Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK Cohort.
Evison M; Barrett E; Cheng A; Mulla A; Walls G; Johnston D; McAleese J; Moore K; Hicks J; Blyth K; Denholm M; Magee L; Gilligan D; Silverman S; Hiley C; Qureshi M; Clinch H; Hatton M; Philipps L; Brown S; O'Brien M; McDonald F; Faivre-Finn C
Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):145-154. PubMed ID: 32978027
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
[TBL] [Abstract][Full Text] [Related]
5. The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.
Shoji F; Haratake N; Akamine T; Takamori S; Katsura M; Takada K; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Feb; 37(2):741-747. PubMed ID: 28179325
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).
Agarwal M; Brahmanday G; Bajaj SK; Ravikrishnan KP; Wong CY
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):691-8. PubMed ID: 19915840
[TBL] [Abstract][Full Text] [Related]
8. Survival and risk model for stage IB non-small cell lung cancer.
Padilla J; Calvo V; Peñalver JC; Zarza AG; Pastor J; Blasco E; París F
Lung Cancer; 2002 Apr; 36(1):43-8. PubMed ID: 11891032
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
10. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
[TBL] [Abstract][Full Text] [Related]
12. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
[TBL] [Abstract][Full Text] [Related]
13. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
[TBL] [Abstract][Full Text] [Related]
14. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Finkle JH; Penney BC; Pu Y
Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
[TBL] [Abstract][Full Text] [Related]
15. [Establishment and evaluation of a prognostic prediction model for patients after complete resection of non-small cell lung cancer and multidisciplinary therapy].
Wei WD; Fu JH; Lin P; Li XD; Yang H; Rong TH; Chen LK
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):672-5. PubMed ID: 19173908
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.
Bergman P; Brodin D; Lewensohn R; de Petris L
Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828
[TBL] [Abstract][Full Text] [Related]
18. [Multivariate survival analysis of patients with stage I NSCLC].
Pei J; Han B; Zhang J; Gu A
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):926-32. PubMed ID: 22152692
[TBL] [Abstract][Full Text] [Related]
19. A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients.
David EA; Andersen SW; Beckett LA; Melnikow J; Kelly K; Cooke DT; Brown LM; Canter RJ
Ann Thorac Surg; 2017 Nov; 104(5):1665-1672. PubMed ID: 28964421
[TBL] [Abstract][Full Text] [Related]
20. Predictive scoring of high-grade histology among early-stage lung cancer patients: The MOSS score.
Woo W; Cha YJ; Park CH; Moon DH; Lee S
Thorac Cancer; 2023 Jul; 14(19):1865-1873. PubMed ID: 37201906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
